Spyre Therapeutics
SYRE
#5743
Rank
A$1.33 B
Marketcap
$22.09
Share price
-5.36%
Change (1 day)
-55.63%
Change (1 year)

EPS for Spyre Therapeutics (SYRE)

EPS in 2024 (TTM): -$109.38

According to Spyre Therapeutics's latest financial reports the company's current EPS (TTM) is -$112.82. In 2023 the company made an earnings per share (EPS) of -$76.77 a decrease over its 2022 EPS that were of -$38.68.

EPS history for Spyre Therapeutics from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$109.3842.47%
2023-$76.7798.46%
2022-$38.68-1%
2021-$39.07-34.21%
2020-$59.39-37.96%
2019-$95.7315.02%
2018-$83.2318.33%
2017-$70.34-18.92%
2016-$86.75120.2%
2015-$39.39-33.55%
2014-$59.28